Direct-to-consumer prescription drug advertising should be banned

CDC and HHS leadership, research integrity, bioethics, regulatory appointments, e-cigarette regulation, and global health funding.

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Drug-class-specific topics including statins, insulin and biologics, continuous medication delivery, and pharmacy distribution systems.